Lord's Mark Industries Secures MHRA Registration for UK IVD Portfolio Expansion
Lord's Mark Industries Limited has achieved MHRA registration in the UK and allied markets for its in vitro diagnostics (IVD) portfolio, including haematological and clinical chemistry analysers. This follows its recent registration for an AI-powered haemodialysis system. The company plans to begin commercial sales of IVD products in the UK by December 2026 and launch a pathology laboratory in January 2027, aiming to expand its healthcare and diagnostics presence internationally.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 38/100.
Outlets measured: businessstandard, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 5 Oct, 07:20 am. Other outlets followed.